Novoic
Entrepreneur First '19London, GB · Founded 2019 · 2 known investors
Novoic develops AI-based software that analyzes speech to detect mild cognitive impairment and early-stage Alzheimer's disease, aiming to enable earlier detection. Its products—including automated speech-based cognitive testing (Storyteller), a screening management dashboard, and a speech-processing API—are used by medical centers and research institutions, primarily in the US.
AI & Machine LearningDigital HealthHealthtech
Founders & leadership
Novoic was founded in 2019 by Emil Fristed and Jack Anthony Weston.
EF
Emil FristedinCofounderEmil completed a Master's in Neuroscience with distinction at the University of Oxford, and previously earned a Bachelor's in Molecular Medicine as the top student in his cohort, during which he was chosen to run an independent Alzheimer's research project. He went on to work in the King Group, a leading auditory neuroscience lab, using machine learning to study sensory processing and how language shifts with neurological disease.
JA
Jack Anthony WestoninCTOJack holds a PhD in Particle Physics from the University of Cambridge and a Master of Physics from the University of Oxford. He has taught as a professor at Oxford and holds a research fellowship at the Cambridge Institute for Theoretical Cosmology.
Investors · 2
Frequently asked questions
- What does Novoic do?
- Novoic develops AI-based software that analyzes speech to detect mild cognitive impairment and early-stage Alzheimer's disease, aiming to enable earlier detection. Its products—including automated speech-based cognitive testing (Storyteller), a screening management dashboard, and a speech-processing API—are used by medical centers and research institutions, primarily in the US.
- Who founded Novoic?
- Novoic was founded by Emil Fristed, Jack Anthony Weston in 2019.
- Who are Novoic's investors?
- Novoic's investors include Anthemis Venture, Entrepreneur First.
- Where is Novoic headquartered?
- Novoic is headquartered in London, GB.